TrialHuman vaccines & immunotherapeutics2023

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females.

Li-Wei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.